Cargando…
Pro: should asymptomatic patients with moderate-to-severe OSA be treated?
Substantial evidence points to a benefit with CPAP on cardiovascular and metabolic outcomes in asymptomatic patients with moderate-to-severe obstructive sleep apnoea http://ow.ly/FUxN30nkTqU
Autor principal: | Ryan, Silke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395978/ https://www.ncbi.nlm.nih.gov/pubmed/30838054 http://dx.doi.org/10.1183/20734735.0340-2018 |
Ejemplares similares
-
Con: should asymptomatic patients with moderate-to-severe
OSA be treated?
por: Vakulin, Andrew, et al.
Publicado: (2019) -
How Should Very Severe Aortic Stenosis Be Defined in Asymptomatic Individuals?
por: Tribouilloy, Christophe, et al.
Publicado: (2019) -
OSAS in children: Where are we?
por: de Almeida, Leila Azevedo, et al.
Publicado: (2015) -
OSA: Treatments beyond CPAP
por: Cammaroto, Giovanni, et al.
Publicado: (2022) -
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
por: Honore, Patrick M., et al.
Publicado: (2021)